Plain-English translation of NCT03649048 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing two different ways of giving cisplatin chemotherapy alongside radiation therapy for locally advanced head and neck cancer. Some patients will receive cisplatin in three high doses (on days 1, 22, and 43), while others will receive it in smaller doses every week. The goal is to find out whether the weekly, lower-dose approach works just as well while reducing serious side effects, especially hearing loss, that can affect your quality of life for years after treatment.
Head and neck cancers are increasingly common in younger patients who have many years of life ahead of them. While this treatment combination works well to cure the cancer, it can cause lasting problems like hearing loss that greatly impact daily life. Researchers want to find a way to treat the cancer effectively while minimizing these long-term side effects.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to receive either three larger doses of cisplatin or weekly smaller doses, all given alongside your radiation therapy. You will need to attend a multidisciplinary clinic evaluation before starting, then complete your full course of radiation treatment (typically 6–7 weeks) with your assigned chemotherapy schedule. You'll also have follow-up visits and hearing tests to monitor how well the treatment is working and to track any side effects over time.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
Canada